Table 3. Ranking by association strength (P value) of the stage 1 tests with p < 0.05: Outcome associations with BMI allele score for original dataset.
Rank | Outcome variable (original data with variable N) | SD change of inverse normal transformed outcome for a 1 SD change of BMI allele score |
||||
---|---|---|---|---|---|---|
Sample size | SD change | 95% CI | P value (adjusted P value)a | Permutation P valueb | ||
1 | Leptin, 9c | 4,249 | 0.138 | 0.11, 0.17 | <0.001 | – |
2 | CRP, 9c | 4,250 | 0.083 | 0.05, 0.11 | <0.001 | – |
3 | Age menarchec | 2,946 | −0.083 | −0.12, −0.05 | <0.001 | – |
4 | HDL, 9 | 4,250 | −0.067 | −0.10, −0.04 | <0.001 (0.002) | 0.008 |
5 | SBP, 7c | 6,013 | 0.049 | 0.02, 0.07 | <0.001 | – |
6 | IL6, 9 | 4,240 | 0.053 | 0.02, 0.08 | 0.001, (0.091) | 0.010 |
7 | Enjoyment of School Score, 4 | 5,807 | 0.041 | 0.02, 0.07 | 0.002, (0.255) | 0.022 |
8 | Self Esteem: Scholastic Competence, 8 | 5,222 | 0.042 | 0.02, 0.07 | 0.002, (0.323) | 0.025 |
9 | Apolipoprotein B, 9 | 4,250 | 0.043 | 0.01, 0.07 | 0.005, (0.788) | 0.028 |
10 | Triglycerides, 9 | 4,250 | 0.042 | 0.01, 0.07 | 0.006, (0.970) | 0.037 |
11 | VLDL, 9 | 4,250 | 0.042 | 0.01, 0.07 | 0.006, (1) | 0.048 |
12 | Apolipoprotein al, 9 | 4,250 | −0.038 | −0.07, −0.01 | 0.012, (1) | 0.046 |
13 | Insulin, 15c | 2,859 | 0.047 | 0.01, 0.08 | 0.012 | – |
14 | Attention/activity symptoms score, 11 | 4,541 | 0.037 | 0.01, 0.07 | 0.013, (1) | 0.055 |
15 | SDQ emotional symptoms score, 6 | 5,748 | −0.030 | −0.06, 0.00 | 0.022, (1) | 0.063 |
16 | Hygiene Score, 4 | 6,231 | 0.028 | 0.00, 0.05 | 0.024, (1) | 0.070 |
17 | Self Esteem: Global Self Worth Score, 8 | 5,214 | 0.031 | 0.00, 0.06 | 0.025, (1) | 0.079 |
18 | FVC: lung function, 8c | 5,276 | 0.030 | 0.00, 0.06 | 0.030 | − |
19 | Burden of compulsions/obsessions score, 7 | 5,684 | 0.028 | 0.00, 0.05 | 0.031, (1) | 0.080 |
20 | Particular fears score, 7 | 5,734 | −0.028 | −0.05, 0.00 | 0.033, (1) | 0.086 |
21 | Glucose, 15c | 2,862 | 0.041 | 0.11, 0.17 | 0.038 | – |
Abbreviations: BMI, body mass index; CI, confidence interval; SD, standard deviation; VLDL, very low density lipoprotein; IL6, interleukin 6; SBP, systolic blood pressure; HDL, high density lipoprotein; VLDL, very low density lipoprotein; SDQ, Strengths and Difficulties Questionnaires; LF, lung function; FVC, forced vital capacity. Full names of variables are given in Supplementary Table 3. All outcomes are transformed to normal distributions using a rank-based inverse normal transformation. Exposure and outcome variables are standardised. Outcome as dependent variable, BMI allele score as independent variable.
aAdjusted P values are adjusted for the 160 tests performed using the Bonferroni correction: pcorrected = poriginal·160. Adjusted P values greater than 1 are rounded to 1. Outcomes in validation set are excluded from Bonferroni correction.
bPermutation P values are generated with permutation testing. Null hypothesis: The outcome variable at rank i in this table would be ranked lower than i if no association was found with the allelic score. We exclude outcomes in validation set such that such that, for instance i = 1 for HDL because all three outcomes ranked higher than HDL are in the validation set).
cVariables that are in the ‘validation set’, that were chosen for inclusion using apriori knowledge of their association with BMI. Adjusted P value are not given for these are they are not part of the main outcome dataset.